-
Story
Innovating for America: How Our New RLT Manufacturing Site Can Help Ensure Continued On Time Delivery to Patients Now and in Future -
Story
What Are GTTs? These Technologies Can Impact How a Gene Functions -
Story
Introducing the GARAGE by iLab: Behind the Scenes at Our New Innovation Hub -
Media Release
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer